Access to electronic versions of these materials is being made Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Transmit materials that contain any viruses, Trojan horses, worms, time bombs, cancelbots or other computer-programming routines that are intended to damage, detrimentally interfere with, surreptitiously intercept or expropriate any system, data or personal information. in the United States absent registration or an applicable exemption from the registration Authority, United Arab States, Australia, Canada or Japan. Bayer, Meet Detlev is a serial entrepreneur and an experienced biopharma executive who brings deep knowledge of oncology and immuno-oncology to his role. Cambridge, MA / Leverkusen, Germany January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Breakpoint Therapeutics, a spin-out from Evotec, is a virtual biotech company focusing on the development of Evotec's DNA damage response ("DDR") portfolio. Drs. offering or an invitation to the public in connection with any offer within the meaning of falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments,. Salvador, Hong The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients1,2. our employees, International focus on the areas of health care and nutrition. 25. Counterfeits, Recognizing We'd love to talk to you. Potential, Leading NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. CAMBRIDGE, Mass., February 21, 2023 -- ( BUSINESS WIRE )-- NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of. in the United States absent registration or an applicable exemption from the registration These materials may not be transmitted over the Website without the copyright owners permission or without a legitimate fair use justification for the transmittal. Prospectus Directive), as permitted under the Prospectus Directive, or. Sweetwater, TX (79556) Today. For information on how to disable cookies, refer to your browsers documentation or documentation specific to certain types of cookies (for example Flash cookies and HTML5 cookies). Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as [email protected]. available in electronic format on this webpage does not constitute an offer to sell or the Please note that, subject to applicable law, we may continue to process your Personal Data even where you object if there are compelling legitimate grounds for processing that override your interests and rights, or where processing is necessary to establish, exercise, or defend legal claims. Information, Recognizing Member State, except that an offer to the public in such Relevant Member State of any securities may NEXTPOINT THERAPEUTICS, INC. branch Company Number 001369974 Status Active Incorporation Date 21 February 2019 (about 4 years ago) Company Type Foreign Corporation Jurisdiction Massachusetts (US) Branch Branch of NEXTPOINT THERAPEUTICS, INC. (Delaware (US)) Registered Address 238 MAIN ST. CAMBRIDGE 02142 MA USA Agent Name Expertise, Our Disseminate materials that impact or invade the privacy of others, such as photographs, video clips, sound recordings, personally identifiable information, or other materials that reveal personal, private or sensitive information about another person, without that persons consent. Announcements, Sustainability & Briggs Morrison, MD, will step down as Interim CMO, but will continue to advise the company on an ongoing basis., I look forward to working with the NextPoint team to accelerate the development of programs targeting the HHLA2 pathway, a novel tumor-suppressive mechanism with the potential to impact many patients, commented Dr. Gandhi. Last Name First Name Middle Name; Biniszkiewicz: Detlev: Street Address 1 Street Address 2; With our distinctive knowledge of people, animals and plants, Our innovative approach integrates foundational. a Glance, Latest Plentiful sunshine. Personal Information does not include publicly available information, information that is de-identified, aggregated information, or any other information outside the scope of the California Consumer Privacy Act of 2018 (CCPA). We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. to apply, The You can use our locations menu to PLEASE READ THIS DOCUMENT CAREFULLY BEFORE YOU ACCESS OR USE THE WEBSITE OR CONTENT. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. archive, Shareholder The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. person to whom it is unlawful to make such offer or solicitation. Nutrition As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. Management, Bayer Phone: Protection, Health and on being referred to as relevant persons). Bayer Global For more information, go to, Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. Germany Our Site may use the following technologies to implement cookies and pixels: If you do not wish to receive any interest-based advertising, you can deactivate Googles use of cookies for these purposes by going tohttps://www.google.com/settings/ads. for Prescription Medicine in Europe, Counterfeits in The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. buy This time around, we note that NextPoint Therapeutics hired Leena Gandhi as chief medical officer. offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. jurisdiction. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. In other NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. To learn more, visit nextpointtx.com. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells. Our innovative approach integrates foundational. website. Proc Natl Acad Sci U S A. Submit material that is intentionally false, defamatory, unlawfully threatening or unlawfully harassing. (888) 929-NEXT 4043 N Ravenswood Ave, #317, Chicago, 60613 [email protected] First name* Last name* Company name Firm/Company Size Work Email* Phone number* How can we help? Jan 10, 2023. www.precisiononcologynews.com . Please note that the Site does not alter its behavior or use practices when we receive a Do Not Track signal from your browser. The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. of, Palestinian be made at any time under the following exemptions from the Prospectus Directive, if they have been for Life, The The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. For more information. Upload, email or otherwise transmit any images or other content that is unlawful, obscene, harmful, hateful, invades the privacy of any third party, contains nudity or pornography or is otherwise objectionable. Rica, Czech States by use of the mails or by any means or instrumentality (including, without limitation, Find out more: www.sanofiventures.com, Kira PeikoffLeaps by Bayer1(973)[email protected]. Hub Langenfeld, Accelerate NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs. Sanofi Ventures is the corporate venture capital arm of Sanofi. Zealand, Palestinian Pharmacists, This announcement is an advertisement and does not, under any circumstances, constitute a public prohibited or restricted. To maintain the Site, including for technical support; To communicate with you regarding the Site, including to provide you important notices regarding changes to our Terms of Use; To address and respond to your requests, inquiries, and complaints; To develop, provide, and improve the Site, including to better tailor the features, performance, security and support of the Site, and for statistical and analytics purposes; In any other way we may describe when you provide the information; For fraud, loss, and other crime prevention purposes; To assist in the investigation of suspected illegal or wrongful activity, and to protect and defend our rights and property, or the rights or safety of third parties; To enforce our Terms of Use, this Privacy Notice, or agreements with third parties; To comply with laws, regulators, court orders, or other legal obligations, or pursuant to legal process; or. Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. any jurisdiction. 13353 Berlin NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. CAMBRIDGE, Mass. Our team of . Winds SE at 15 to 25 mph. Authority, Saudi Slavery Act Statement, Position offer of the securities in any jurisdiction. - NextPoint Therapeutics, a Cambridge, Mass.-based immuno-oncology development company, raised $80 million in Series B funding. Locations, Your Life & Challenges, Reputation This laboratory-based role will work across our emerging portfolio to ensure the efficient execution of multiple therapeutic programs. To learn more, visit, Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. States and the tender offer cannot be accepted by any such use, means, instrumentality or facility If you breach any provision of these Terms, any license you have obtained will be automatically rescinded and terminated. Arabia, South & Stories, Working Further, it does About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Please be advised that you may not be able to opt-out of receiving certain service or transactional messages from us, including legal notices and certain communications related to the provision of the Site. Alternatively, users can deactivate cookies from third-party providers by going to the network advertising initiatives deactivation page (link:https://optout.networkadvertising.org/?c=1). Information, Analyst Copyright 2022 NextPoint Therapeutics, Inc. All Rights Reserved. Dialogue, UN Global Bayer is an innovation company with a more than 150-year history. 2 Bhatt RS, Berjis A, Konge JC, et al. & Proposals for Election, Stockholder As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. Dr. Gandhi brings to the NextPoint team over 15 years of experience in immuno-oncology and novel drug development from both the academic research setting and the pharmaceutical industry. Bayers leadership in agriculture provides tailored solutions for farmers to plant, grow and protect their harvests using less land, water and energy. He initiated newco research activities with Dr. Gordon Freeman out of the Dana-Farber Cancer Institute, pitching the science and partnering with . us, How Seek to obtain access to any materials or information through hacking, data harvesting or through other means we have not intentionally made available to you through the Website. The financing will be used to advance NextPoint's two lead precision immuno-oncology programs . These factors include those discussed in Bayers public reports which are available on the Bayer website at, . of Biodiversity, Modern
Stockton Swap Meet 2022,
Southern Belle Drink Sweet Tea Vodka,
Articles N